The production and bioactivity of prodigiosin: quo vadis?

Drug Discov Today. 2020 May;25(5):828-836. doi: 10.1016/j.drudis.2020.03.017. Epub 2020 Apr 3.

Abstract

Prodigiosin (PG), a red tripyrrole pigment, belongs to a member of the prodiginine family and is normally secreted by various sources including Serratia marcescens and other Gram-negative bacteria. The studies of PG have received innovative devotion as a result of reported antimicrobial, larvicidal and anti-nematoid immunomodulation and antitumor properties, owing to its antibiotic and cytotoxic activities. This review provides a comprehensive summary of research undertaken toward the isolation and structural elucidation of the prodiginine family of natural products. Additionally, the current evidence-based understanding of the biological activities and medicinal potential of PG is employed to determine the efficacy, with some reports of information related to pharmacokinetics, pharmacodynamics and toxicology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biological Products / pharmacology
  • Humans
  • Prodigiosin / analogs & derivatives
  • Prodigiosin / biosynthesis*
  • Prodigiosin / pharmacology*
  • Serratia marcescens / metabolism

Substances

  • Biological Products
  • prodiginine
  • Prodigiosin